O'DonnellMJChinSLRangarajanSXavierDLiuLZhangH, et al.INTERSTROKE investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet2016; 388: 761–775.
4.
BraininMFeiginVMartinsS, et al.Cut stroke in half: polypill for primary prevention in stroke. Int J Stroke2018; 13: 633–647.
5.
RoshandelGKhoshniaMPoustchiHHemmingKKamangarFGharaviA, et al.Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial. Lancet2019; 394: 672–683.
6.
BraininMFeiginVLNorrvingB, et al.Global prevention of stroke and dementia: the WSO Declaration. Lancet Neurol2020; 19: 487–488.
7.
Kim J, Thayabaranathan T, Donnan GA, Howard G, Howard VJ, Rothwell PM, et al. Global stroke statistics 2019. Int J Stroke 2020; 15(8): 819–838.
8.
NortonSMatthewsFEBarnesDEYaffeKBrayneC. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol2014; 13: 788–794.
9.
DebetteSSchillingSDuperronMGLarssonSCMarkusHS. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurol2019; 76: 81–94.
10.
SPRINT MIND Investigators for the SPRINT Research Group, Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA 2019; 321: 553–561.
11.
RosenbergAMangialascheFNganduTSolomonAKivipeltoM. Multidomain interventions to prevent cognitive impairment, Alzheimer's disease, and dementia: from FINGER to world-wide FINGERS. J Prev Alzheimers Dis2020; 7: 29–36.